Earnings Feed
Start Free
BrightSpring Health Services, Inc.·4

Mar 6, 7:45 PM ET

ROUSSEAU JON B 4

4 · BrightSpring Health Services, Inc. · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

BrightSpring CEO Jon B. Rousseau Sells 220,000 Shares

What Happened
Jon B. Rousseau, Chairman, President and Chief Executive Officer of BrightSpring Health Services (BTSG), exercised 220,000 options and then sold 220,000 shares on March 4, 2026. The options were exercised at $6.37 per share (cost ≈ $1,401,400) and the shares were sold in a registered offering at $41.15 per share (proceeds ≈ $9,053,000). In addition, the filing reports new equity awards: RSUs granted on March 5, 2026 and performance-based awards that vested after performance conditions were satisfied.

Key Details

  • Primary transactions: exercised 220,000 options @ $6.37 (acquired) and sold 220,000 shares @ $41.15 (disposed) on 2026-03-04. Sale proceeds ≈ $9,053,000; exercise cost ≈ $1,401,400. (Footnote F1: sale was pursuant to a registered public offering closed Mar 4, 2026 at $41.15, before underwriting discounts/commissions.)
  • Grants recorded: 186,845 RSUs granted on 2026-03-05 (vest in 12 equal quarterly installments beginning 4/25/2026) (Footnote F2). Additional derivative awards/performance-option vesting reported on 3/4–3/5 (see F4–F6).
  • Performance options: previously awarded performance-based options vested after performance conditions were satisfied on March 3, 2026; those options are fully vested (F4, F5).
  • Reporting/ownership notes: the filer disclaims beneficial ownership of certain indirectly owned securities except to the extent of a pecuniary interest (F3).
  • Shares owned after the transactions: not specified in the provided summary of this Form 4.
  • Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 — appears to be timely (no late filing flag).

Context
This was a paired exercise-and-sale: the insider exercised options at a low strike and sold the resulting shares in a registered offering the same day. The filing also reflects new RSU awards (vesting quarterly) and the vesting of previously granted performance options after performance goals were met. These types of filings are factual disclosures of transactions and awards; they do not by themselves indicate the insider’s broader view of company prospects.

Insider Transaction Report

Form 4
Period: 2026-03-04
BrightSpring Health Services, Inc.BTSG
ROUSSEAU JON B
DirectorSee Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-04$6.37/sh+220,000$1,401,400→ 1,243,880 total
  • Sale

    Common Stock

    [F1]
    2026-03-04$41.15/sh−220,000$9,053,000→ 1,023,880 total
  • Award

    Common Stock

    [F2]
    2026-03-05+186,845→ 1,210,725 total
  • Award

    Stock Options (Right to Buy)

    [F4]
    2026-03-04+955,823→ 1,516,064 total
    Exercise: $6.37Exp: 2029-10-16→ Common Stock (955,823 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    [F5]
    2026-03-04−220,000→ 1,296,064 total
    Exercise: $6.37Exp: 2029-10-16→ Common Stock (220,000 underlying)
  • Award

    Stock Options (Right to Buy)

    [F6]
    2026-03-05+458,008→ 458,008 total
    Exercise: $41.77Exp: 2036-03-05→ Common Stock (458,008 underlying)
Holdings

  • Common Stock

    [F3]
    (indirect: By Trust)
    369,763

  • Stock Options (Right to Buy)

    [F5][F3]
    (indirect: By Trust)
    Exercise: $6.37Exp: 2029-10-16→ Common Stock (534,676 underlying)
    534,676

  • Stock Options (Right to Buy)

    [F5][F3]
    (indirect: By Trust)
    Exercise: $6.37Exp: 2029-10-16→ Common Stock (377,602 underlying)
    377,602
Footnotes (6)
  • [F1]These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.
  • [F2]On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in twelve equal quarterly installments commencing on April 25, 2026. Each RSU represents a contingent right to receive one share of common stock upon settlement.
  • [F3]The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.
  • [F4]No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on October 16, 2019, vesting subject to performance conditions that were subsequently satisfied on March 3, 2026. The Performance Options are fully vested.
  • [F5]These options are fully vested.
  • [F6]Options vest in twelve equal quarterly installments commencing on April 25, 2026.
Signature
/s/ Jennifer Phipps, as Attorney-in-Fact|2026-03-06

Documents

1 file
  • 4
    form4.xmlPrimary